BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24909514)

  • 1. RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation.
    Lu C; Zhou LY; Xu HJ; Chen XY; Tong ZS; Liu XD; Jia YS; Chen Y
    Acta Pharmacol Sin; 2014 Jul; 35(7):929-36. PubMed ID: 24909514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation.
    Lu B; Gong X; Wang ZQ; Ding Y; Wang C; Luo TF; Piao MH; Meng FK; Chi GF; Luo YN; Ge PF
    Acta Pharmacol Sin; 2017 Nov; 38(11):1543-1553. PubMed ID: 28816233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells.
    Zhang Z; Li HM; Zhou C; Li Q; Ma L; Zhang Z; Sun Y; Wang L; Zhang X; Zhu B; Hong YS; Wu CZ; Liu H
    J Exp Clin Cancer Res; 2016 Sep; 35(1):149. PubMed ID: 27658586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468.
    Natarajan S; Ranganathan M
    Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways.
    Li Y; Tian X; Liu X; Gong P
    Carcinogenesis; 2018 May; 39(5):700-707. PubMed ID: 29546393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambrosin sesquiterpene lactone exerts selective and potent anticancer effects in drug-resistant human breast cancer cells (MDA-MB-231) through mitochondrial mediated apoptosis, ROS generation and targeting Akt/β-Catenin signaling pathway.
    Fan S; Cui Y; Hu Z; Wang W; Jiang W; Xu H
    J BUON; 2020; 25(5):2221-2227. PubMed ID: 33277839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
    Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
    Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of NF-κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells.
    Li C; Guo S; Shi T
    Cell Biochem Funct; 2013 Apr; 31(3):263-8. PubMed ID: 23086737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centaurea cyanus extracted 13-O-acetylsolstitialin A decrease Bax/Bcl-2 ratio and expression of cyclin D1/Cdk-4 to induce apoptosis and cell cycle arrest in MCF-7 and MDA-MB-231 breast cancer cell lines.
    Keyvanloo Shahrestanaki M; Bagheri M; Ghanadian M; Aghaei M; Jafari SM
    J Cell Biochem; 2019 Oct; 120(10):18309-18319. PubMed ID: 31161672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells.
    Ghorbani-Abdi-Saedabad A; Hanafi-Bojd MY; Parsamanesh N; Tayarani-Najaran Z; Mollaei H; Hoshyar R
    Mol Biol Rep; 2020 Aug; 47(8):5807-5815. PubMed ID: 32686017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
    Jiang Q; Zhang H; Zhang P
    J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of TIGAR sensitizes the antitumor effect of physapubenolide through increasing intracellular ROS levels to trigger apoptosis and autophagosome formation in human breast carcinoma cells.
    Ma T; Zhang Y; Zhang C; Luo JG; Kong LY
    Biochem Pharmacol; 2017 Nov; 143():90-106. PubMed ID: 28774732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
    Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
    Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
    Gupta P; Srivastava SK
    BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells.
    McLean LS; Watkins CN; Campbell P; Zylstra D; Rowland L; Amis LH; Scott L; Babb CE; Livingston WJ; Darwanto A; Davis WL; Senthil M; Sowers LC; Brantley E
    Chem Res Toxicol; 2015 May; 28(5):855-71. PubMed ID: 25781201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells.
    Kim KH; Kim JY; Kwak JH; Pyo S
    Phytomedicine; 2015 Aug; 22(9):820-8. PubMed ID: 26220629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIP2A is a target of bortezomib in human triple negative breast cancer cells.
    Tseng LM; Liu CY; Chang KC; Chu PY; Shiau CW; Chen KF
    Breast Cancer Res; 2012 Apr; 14(2):R68. PubMed ID: 22537901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.